Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

N-[4-Cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide

N-[4-Cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide is listed in the pharmaceutical impurity collection under CAS 316373-92-9. Its represented structure has formula C12H11F3N2O3 and a calculated molecular weight of 288.23 g/mol.

2D chemical structure

H O H O O H N N F F F

Chemical identity

Catalog name
N-[4-Cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide
Common name
Not available
Chemical name
N-[4-cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide
CAS
316373-92-9
SMILES
CC(O)(CO)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1
InChI
InChI=1S/C12H11F3N2O3/c1-11(20,6-18)10(19)17-8-3-2-7(5-16)9(4-8)12(13,14)15/h2-4,18,20H,6H2,1H3,(H,17,19)
InChIKey
IIBBSRFFFOOJBY-UHFFFAOYSA-N
Associated API
Bicalutamide

Record ID: A629ae96d865e

Computed properties

C12H11F3N2O3 Molecular formula
288.225 g/molMolecular weight
288.0722 DaMonoisotopic exact mass
93.35 ŲTopological polar surface area
1.2589 Calculated LogP (Wildman–Crippen)
62.4983 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
3 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C F H N O 0 3 6 9 12 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight288.22540.60
Calculated LogP (Wildman–Crippen)1.258929.36
Topological polar surface area93.3568.05
Hydrogen-bond acceptors450.68
Hydrogen-bond donors381.39
Rotatable bonds (strict)337.08

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC12H11F3N2O3dimensionless
Molecular weight288.225g/mol
Monoisotopic exact mass288.0722Da
Topological polar surface area93.35Ų
Calculated LogP (Wildman–Crippen)1.2589dimensionless
Molar refractivity (Wildman–Crippen)62.4983cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors3count
Rotatable bonds (strict)3count
Heavy atoms20count
Heteroatoms8count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.3333fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area111.8101Ų
Valence electrons108count
Radical electrons0count
Bertz complexity562.0465index
Balaban J3.1193index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for N-[4-Cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide

Qualification and safety assessment of N-[4-Cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide

Explore toxicological qualification of N-[4-Cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide and ICH M7 mutagenic impurity assessment of N-[4-Cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for N-[4-Cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide and acceptable intake and limit justification for N-[4-Cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for N-[4-Cyano-3-(trifluoromethyl)phenyl]-2,3-dihydroxy-2-methylpropanamide

Explore Altox services and software through the Altox Pharma-Hub.